Company: DVAX
Filing Date: 2025-04-15
Form Type: CORRESP
Source: 0000930413-25-001253
Chunk: 0

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: CORRESP
Chunk 0
---
April 14, 2025

Office of Mergers and Acquisitions

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Christina Chalk

| Re: | Dynavax Technologies Corporation                    
 PREC14A Preliminary Proxy Statement on Schedule 14A 
 Filed on April 3, 2025                              
 File No. 001-34207                                  |

Dear Ms. Chalk:

On behalf of Dynavax
Technologies Corporation (“Dynavax” or the “Company”), we submit this letter
in response to comments received from the staff (the “Staff”) of the U.S. Securities and Exchange Commission
(the “Commission”) by letter dated April 11, 2025 (the “Comment Letter”) with
respect to the Company’s Preliminary Proxy Statement on Schedule 14A filed with the Commission on April 3, 2025 (the “Preliminary Proxy Statement”). The Company has revised the Preliminary Proxy Statement and is filing a revised preliminary proxy
statement (the “Revised Preliminary Proxy Statement”) concurrently herewith. For the convenience of the
Staff, the numbering of the paragraphs below corresponds to the numbering of the comment in the Comment Letter, the text of which
we have incorporated into this response letter for convenience in italicized type and which is followed by the Company’s
response.

1. Please revise the biographical information for each of Board Nominees Lauren Silvernail and Emilio Emini to cover each individual’s business experience for the past five years. Refer to Item 7(a) of Schedule 14A and Item 401(e) of Regulation S-K. By way of example only, we note that you have not included disclosure regarding Ms. Silvernail’s principal occupations and employment, if any, from May 2022 until her appointment to the Board in February 2025.

The Company respectfully acknowledges
the Staff’s comment, and notes that both Lauren Silvernail and Emilio Emini are retired from their respective previous principal
occupations. Accordingly, the Company respectfully submits that the biographical information provided for each of Ms. Silvernail
and Dr. Emini describes the business experience of such nominees, including their principal occupations and employment, for the
past five years. In the Revised Preliminary Proxy Statement, the Company has revised the disclosure on page 19 of the Preliminary
Proxy Statement as marked in underlined blue text below